LCMS Bioanalysis of Antibody Drugs Using Fab-Selective Proteolysis nSMOL - Trastuzumab analysis -
Aplikace | 2017 | ShimadzuInstrumentace
LC/MS, LC/MS/MS, LC/QQQ
ZaměřeníKlinická analýza
VýrobceShimadzu
Klíčová slovansmol, trastuzumab, antibody, structure, peptide, confirmation, accuracy, nsmoltm, quantitation, iyptngytr, cdr, proteolysis, lcms, mrm, fab, pharmacokinetic, average, assay, bioanalysis, guideline, signature, set, drugs, immunosorvent, concentration, protocol, transition, peptides, criteria, succeeded, data, news, selective, thaw, preclinical, complementarity, validation, fulfills, chief, plasma, kit, human, esi, fulfilled, shimadzu, method, paradigm, drug, shortening, interface
Podobná PDF
LCMS Bioanalysis of Antibody Drugs Using Fab-Selective Proteolysis nSMOL - Trastuzumab analysis
2021|Shimadzu|Aplikace
LAAN-A-LM-E116B Application News No. C145B nSMOLTM Antibody BA Kit LCMS Bioanalysis of Antibody Drugs Using Fab-Selective Proteolysis nSMOL - Trastuzumab analysis - nSMOLTM Antibody BA Kit Features nSMOL is Shimadzu's completely new and breakthrough technology that enables selective proteolysis…
Klíčová slova
nsmol, nsmoltrastuzumab, trastuzumabantibody, antibodystructure, structureconfirmation, confirmationaccuracy, accuracynsmoltm, nsmoltmquantitation, quantitationpeptide, peptideiyptngytr, iyptngytrproteolysis, proteolysislcms, lcmsmrm, mrmaverage, averagefab
LCMS Bioanalysis of Antibody Drugs Using Fab-Selective Proteolysis nSMOL - Part 3 - Nivolumab analysis -
2017|Shimadzu|Aplikace
LAAN-A-LM-E118A Application News No. C147A nSMOLTM Antibody BA Kit LCMS Bioanalysis of Antibody Drugs Using Fab-Selective Proteolysis nSMOL - Part 3 - Nivolumab analysis - nSMOLTM Antibody BA Kit Features nSMOL is Shimadzu's completely new and breakthrough technology that…
Klíčová slova
nivolumab, nivolumabnsmol, nsmolantibody, antibodystructure, structureaccuracy, accuracynsmoltm, nsmoltmpeptides, peptidesimmunological, immunologicalconfirmation, confirmationdrugs, drugsvalidation, validationaverage, averageimmune, immunequantitation, quantitationbioanalysis
LCMS Bioanalysis of Antibody Drugs Using Fab-Selective Proteolysis nSMOL - Part 3 - Nivolumab analysis -
2017|Shimadzu|Aplikace
LAAN-A-LM-E118A Application News No. C147A nSMOLTM Antibody BA Kit LCMS Bioanalysis of Antibody Drugs Using Fab-Selective Proteolysis nSMOL - Part 3 - Nivolumab analysis - nSMOLTM Antibody BA Kit Features nSMOL is Shimadzu's completely new and breakthrough technology that…
Klíčová slova
nivolumab, nivolumabnsmol, nsmolstructure, structureantibody, antibodyaccuracy, accuracynsmoltm, nsmoltmpeptides, peptidesimmunological, immunologicalconfirmation, confirmationdrugs, drugsvalidation, validationaverage, averageimmune, immunequantitation, quantitationbioanalysis
LCMS Bioanalysis of Antibody Drugs Using Fab-Selective Proteolysis nSMOL- Part 2 - Bevacizumab analysis -
2017|Shimadzu|Aplikace
LAAN-A-LM-E117A Application News No. C146A nSMOLTM Antibody BA Kit LCMS Bioanalysis of Antibody Drugs Using Fab-Selective Proteolysis nSMOL- Part 2 - Bevacizumab analysis - nSMOLTM Antibody BA Kit Features nSMOL is Shimadzu's completely new and breakthrough technology that enables…
Klíčová slova
antibody, antibodybevacizumab, bevacizumabconfirmation, confirmationstructure, structurequantitation, quantitationnsmol, nsmolhuman, humanmrm, mrmftfsldtsk, ftfsldtsknsmoltm, nsmoltmaccuracy, accuracydrugs, drugsplasma, plasmaproteolysis, proteolysischromatograms
